The Cardioprotective Mechanism of Phenylaminoethyl Selenides (PAESe) Against Doxorubicin-Induced Cardiotoxicity Involves Frataxin

Doxorubicin (DOX) is an anthracycline cancer chemotherapeutic that exhibits cumulative dose-limiting cardiotoxicity and limits its clinical utility. DOX treatment results in the development of morbid cardiac hypertrophy that progresses to congestive heart failure and death. Recent evidence suggests...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Xiaoyu, Eggert, Mathew, Yoo, Sieun, Patel, Nikhil, Zhong, Juming, Steinke, Ian, Govindarajulu, Manoj, Turumtay, Emine Akyuz, Mouli, Shravanthi, Panizzi, Peter, Beyers, Ronald, Denney, Thomas, Arnold, Robert, Amin, Rajesh H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072348/
https://www.ncbi.nlm.nih.gov/pubmed/33912028
http://dx.doi.org/10.3389/fphar.2020.574656

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072348/
https://www.ncbi.nlm.nih.gov/pubmed/33912028
http://dx.doi.org/10.3389/fphar.2020.574656

Ejemplares similares